v3.26.1
Business Combination and Related Transactions - Schedule of Pro Forma Information, Adjustments (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
An increase in additional stock-based compensation expense related to shares issued to key Stereolabs employees in the acquisition that are considered compensatory in the post business combination periods due to the additional service requirement, net of the stock compensation expense already reflected in actual historical results.    
Business Combination [Line Items]    
Net loss $ (303) $ (780)
A decrease (increase) in additional stock-based compensation expense related to the impact of the acceleration of Stereolabs warrants that vested at the close of the Stereolabs acquisition.    
Business Combination [Line Items]    
Net loss 207 (207)
StereoLabs    
Business Combination [Line Items]    
Net loss (24,245) (31,848)
StereoLabs | An increase in amortization expense related to the fair value of acquired identifiable intangible assets, net of the amortization expense already reflected in actual historical results.    
Business Combination [Line Items]    
Net loss (484) (1,184)
StereoLabs | A decrease (increase) in expenses related to the transaction expenses. This amount includes $3.0 million in transaction expenses incurred by the sellers.    
Business Combination [Line Items]    
Net loss 4,137 $ (8,022)
StereoLabs | Seller Acquisition-Related Cost    
Business Combination [Line Items]    
Net loss $ 3,000